Skip to Main Content
++

Nadine Abi-Jaoudeh, MD

++

Physician, Assistant Professor

++

Radiology & Imaging Sciences

++

National Institutes of Health

++

Bethesda, Maryland

++

Hepatocellular Carcinoma

++
++

Ivan Aksentijevich, MD

++

Virginia Cancer Specialists

++

Specialist in Medical Oncology and Hematology

++

Alexandria, Virginia

++

Leukemia, Acute Lymphoblastic (ADULT); Leukemia, Acute Myeloid

++
++

Carmen Joseph Allegra, MD

++

Professor and Chief Hematology and Oncology

++

Department of Medicine

++

University of Florida Health

++

Gainesville, Florida

++

Colorectal Cancer

++
++

Kenneth C. Anderson, MD

++

Professor of Medicine, Department of Medicine,

++

Harvard Medical School

++

Physician, Oncology, Brigham and Women's Hospital

++

Medical Director, Kraft Family Blood Center,

++

Dana-Farber Cancer Institute

++

Boston, Massachusetts

++

Multiple Myeloma

++
++

Andrea Apolo, MD

++

Head, Bladder Cancer Section

++

Genitourinary Malignancies Branch

++

Center for Cancer Research, National Cancer Institute

++

National Institutes of Health

++

Bethesda, Maryland

++

Bladder Cancer

++
++

Dean Bajorin, MD

++

Member and Professor of Medicine

++

Genitourinary Oncology Service

++

Memorial Sloan-Kettering Cancer Center

++

New York, New York

++

Bladder Cancer

++
++

John R. Bartholomew, MD, FACC, MSVM

++

Professor of Medicine and

++

Section Head of Vascular Medicine

++

Cardiovascular Medicine and Hematology

++

Cleveland Clinic

++

Cleveland, Ohio

++

Heparin-Induced Thrombocytopenia

++
++

James C. Barton, MD

++

Medical Director, Southern Iron Disorders Center

++

Clinical Professor of Medicine

++

University of Alabama at Birmingham

++

Birmingham, Alabama

++

Hemochromatosis

++
++

Susan Bates, MD

++

Senior Investigator

++

Head, Molecular Therapeutics Section

++

Medical Oncology

++

National Cancer Institute, National Institutes of Health

++

Bethesda, Maryland

++

Renal Cell Cancer

++
++

Kenneth A. Bauer, MD

++

Professor of Medicine, Harvard Medical School

++

Director, Thrombosis Clinical Research,

++

Beth Israel Deaconess Medical Center

++

Boston, Massachusetts

++

The Hypercoagulable State

++
++

Ann Berger, MSN, MD

++

Chief, Pain and Palliative Care Service

++

National Institutes of Health Clinical Center

++

Bethesda, Maryland

++

Cancer Pain: Assessment and Management

++
++

Giada Bianchi, MD

++

Department of Medical Oncology

++

Dana Farber Cancer Institute

++

Harvard Medical School

++

Boston, Massachusetts

++

Multiple Myeloma

++
++

Michael R. Bishop, MD

++

Professor of Medicine

++

Director, Hematopoietic Stem Cell Transplantation Program

++

The University of Chicago Medicine

++

Chicago, Illinois

++

Complications and Follow-Up After Hematopoietic Cell Transplantation

++
++

Jean-Yves Blay, MD

++

Professor of Medicine in Medical Oncology

++

Head of the Medical Oncology Department

++

Centre Leon Berard of the Université Claude Bernard

++

Scientific Director, Canceropole Lyon Rhône Alpes

++

Lyon, France

++

Sarcomas

++
++

George J. Bosl, MD

++

Chair, Department of Medicine, and

++

Member, Memorial Sloan Kettering Cancer Center

++

Professor of Medicine, Weill Cornell Medical College

++

Testicular Cancer

++
++

Leslie Boyd, MD

++

Assistant Professor of Gynecology

++

Perlmutter Cancer Center

++

NYU Langone Medical Center

++

New York, New York

++

Vaginal Cancer

++
++

Michael M. Boyiadzis, MD, MHSc

++

Associate Professor of Medicine

++

Division of Hematology-Oncology

++

Department of Medicine

++

University of Pittsburgh School of Medicine

++

University of Pittsburgh Cancer Institute

++

Pittsburgh, Pennsylvania

++

Leukemia, Acute Lymphoblastic (ADULT); Leukemia, Acute Myeloid; Complications and Follow-Up After Hematopoietic Cell Transplantation; Aplastic Anemia; Myelodysplastic Syndromes

++
++

Kathleen A. Calzone, PhD, RN, APNG, FAAN

++

Senior Nurse Specialist, Research

++

National Cancer Institute

++

Center for Cancer Research, Genetics Branch

++

Bethesda, Maryland

++

Cancer Screening; Genetics of Common Inherited Cancer Syndromes

++
++

Carla Casulo, MD

++

Assistant Professor of Medicine

++

University of Rochester Medical Center at Strong Memorial Hospital

++

Rochester, New York

++

Lymphoma, Non-Hodgkin

++
++

Julia Lee Close, MD

++

Assistant Professor, University of Florida

++

Section Chief, Hematology/Oncology,

++

Gainesville VA Medical Center

++

Gainesville, Florida

++

Colorectal Cancer

++
++

Jennifer Cuellar-Rodriguez, MD

++

Staff Clinician

++

Laboratory of Clinical Infectious Diseases

++

National Institute of Allergy and Infectious Diseases

++

Bethesda, Maryland

++

Fever and Neutropenia

++
++

William L. Dahut, MD

++

Principal Investigator

++

Medical Oncology

++

Genitourinary Malignancies Branch

++

Center for Cancer Research

++

National Cancer Institute, National Institutes of Health

++

Bethesda, Maryland

++

Prostate Cancer

++
++

Nancy E. Davidson, MD

++

Director, University of Pittsburgh Cancer Institute

++

UPMC Cancer Center

++

Associate Vice Chancellor for Cancer Research

++

Professor of Medicine, University of Pittsburgh

++

Pittsburgh, Pennsylvania

++

Breast Cancer

++
++

Michael W.N. Deininger, MD, PhD

++

Chief, Division of Hematology and Hematologic Malignancies

++

M.M. Wintrobe Professor of Medicine

++

University of Utah

++

Huntsman Cancer Institute

++

Salt Lake City, Utah

++

Leukemia, Chronic Myelogenous

++
++

Bruce J. Dezube, MD

++

Associate Professor of Medicine

++

Beth Israel Deaconess Medical Center

++

Harvard Medical School

++

Boston, Massachusetts

++

HIV-Related Malignancies

++
++

Volker Diehl, MD

++

Emeritus Professor of Medicine, Hematology, Oncology

++

University of Cologne

++

Germany

++

Lymphoma, Hodgkin

++
++

Brian J. Druker, MD

++

Director, Oregon Health & Science University Knight Cancer Institute

++

JELD-WEN Chair of Leukemia Research

++

Investigator, Howard Hughes Medical Institute

++

Portland, Oregon

++

Leukemia, Chronic Myelogenous

++
++

Dennis A. Eichenauer, MD

++

First Department of Internal Medicine and German

++

Hodgkin Study Group

++

University Hospital Cologne

++

Cologne, Germany

++

Lymphoma, Hodgkin

++
++

Sara Ekeblad, MD, PhD

++

Uppsala University Hospital

++

Stockholm, Sweden

++

Pancreatic Endocrine Tumors

++
++

Jennifer Eng-Wong, MD, MPH

++

Assistant Medical Director

++

Genentech

++

South San Francisco, California

++

Cancer Screening

++
++

Jonas W. Feilchenfeldt, MD

++

Attending Physician

++

FMH Internal Medicine and Medical Oncology

++

Department of Medical Oncology

++

Hôpital du Valais

++

Sion, Switzerland

++

Gastric Cancer

++
++

Darren R. Feldman, MD

++

Assistant Member, Department of Medicine

++

Memorial Sloan Kettering Cancer Center, and

++

Assistant Professor in Medicine, Weill Cornell Medical College

++

New York, New York

++

Testicular Cancer

++
++

Enriqueta Felip, MD, PhD

++

Department of Medical Oncology

++

Vall d'Hebron University Hospital

++

Barcelona, Spain

++

Lung Cancer

++
++

Howard Fine, MD

++

Director, Division of Hematology and Oncology

++

Director, NYU Brain Tumor Center

++

Deputy Director, NYU Cancer Institute

++

Director, Bellevue Hospital Cancer Center

++

The New York University (NYU) Langone Medical Center

++

NYU Cancer Institute

++

New York, New York

++

Brain Cancer

++
++

Richard Fisher, MD

++

President and CEO

++

Fox Chase Cancer Center - Temple Health

++

Senior Associate Dean

++

Temple University School of Medicine

++

Philadelphia, Pennsylvania

++

Lymphoma, Non-Hodgkin

++
++

Tito Fojo, MD, PhD

++

Senior Investigator

++

Medical Oncology

++

Center for Cancer Research

++

National Cancer Institute

++

National Institutes of Health

++

Bethesda, Maryland

++

Adrenocortical Cancer; Pheochromocytoma; Sarcomas; Guidelines for Chemotherapy Dosage Adjustment; Oncologic Emergencies

++
++

Kenneth Foon, MD

++

Vice President, Global Medical Affairs, Lymphoma and CLL

++

Medical Affairs

++

Celgene Corporation

++

Summit, New Jersey

++

Leukemia, Chronic Lymphocytic

++
++

James N. Frame, MD, FACP

++

Clinical Professor of Medicine

++

Robert C. Byrd Health Sciences Center

++

West Virginia University School of Medicine

++

Medical Director, David Lee Cancer Center

++

Charleston Area Medical Center Health Systems

++

Charleston, West Virginia

++

Indications for Growth Factors in Hematology-Oncology;

++

Indications for Bone-Modifying Agents in Hematology-Oncology;

++

Heparin-Induced Thrombocytopenia; Autoimmune Hemolytic Anemia;

++

Sickle Cell Disease: Acute Complications

++
++

Jonathan W. Friedberg, MD, MMSc

++

Director, James P. Wilmot Cancer Center

++

Samuel Durand Professor of Medicine and Oncology

++

University of Rochester

++

Rochester, New York

++

Lymphoma, Non-Hodgkin

++
++

Michael Fuchs, MD

++

Head of the Trial Coordination Center German Hodgkin Study Group

++

Department of Internal Medicine

++

University Hospital of Cologne

++

Cologne, Germany

++

Lymphoma, Hodgkin

++
++

Naseema Gangat, MD

++

Assistant Professor of Medicine

++

Division of Hematology

++

Mayo Clinic

++

Rochester, Minnesota

++

Myeloproliferative Neoplasms

++
++

Juan C. Gea-Banacloche, MD

++

Chief, Infectious Diseases Consultation Service

++

Experimental Transplantation and Immunology Branch

++

National Cancer Institute, National Institute of Health

++

Bethesda, Maryland

++

Fever and Neutropenia; Complications and Follow-Up After Hematopoietic Cell Transplantation

++
++

James N. George, MD

++

George Lynn Cross Professor

++

Departments of Medicine, Biostatistics & Epidemiology

++

University of Oklahoma Health Sciences Center

++

Oklahoma City, Oklahoma

++

Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome; Idiopathic Thrombocytopenic Purpura

++
++

Irene M. Ghobrial, MD

++

Associate Professor of Medicine

++

Dana-Farber Cancer Institute

++

Harvard Medical School

++

Boston, Massachusetts

++

Multiple Myeloma

++
++

Giuseppe Giaccone, MD, PhD

++

Associate Director for Clinical Research

++

Georgetown Lombardi Comprehensive Cancer Center

++

Director of Clinical Research, MedStar Georgetown Health Cancer

++

Network's Washington Region

++

Georgetown University Medical Center

++

Washington, DC

++

Thymic Malignancies

++
++

Amanda L. Gillespie-Twardy, MD

++

University of Pittsburgh School of Medicine

++

Pittsburgh, Pennsylvania

++

Melanoma

++
++

Eli Glatstein, MD

++

Professor, Department of Radiation Oncology

++

University of Pennsylvania

++

Philadelphia, Pennsylvania

++

Radiation Complications

++
++

Ann Gramza, MD

++

Staff Clinician

++

Center for Cancer Research

++

National Cancer Institute, NIH

++

Bethesda, Maryland

++

Thyroid Cancer

++
++

F. Anthony Greco, MD

++

Clinical Researcher and Director

++

Sarah Cannon Research Institute

++

Nashville, Tennessee

++

Carcinoma of Unknown Primary

++
++

Tim Greten, MD, PhD

++

Senior Investigator

++

Gastrointestinal Malignancy Section

++

Center for Cancer Research

++

National Cancer Institute

++

Bethesda, Maryland

++

Biliary: Gallbladder Cancer and Cholangiocarcinoma; Hepatocellular Carcinoma

++
++

Thomas E. Hughes, PharmD, BCOP

++

Oncology Clinical Pharmacy Specialist

++

Pharmacy Department

++

National Institutes of Health Clinical Center

++

Bethesda, Maryland

++

Prophylaxis and Treatment of Chemotherapy-Induced Nausea and Vomiting

++
++

Jimmy Hwang, MD

++

Chief, GI Medical Oncology

++

Levine Cancer Institute

++

Carolinas Healthcare System

++

Charlotte, North Carolina

++

Esophageal Cancer

++
++

Rachel C. Jankowitz, MD

++

Assistant Professor of Medicine

++

University of Pittsburgh Cancer Institute

++

UPMC Magee Women's Cancer Program

++

Pittsburgh, Pennsylvania

++

Breast Cancer

++
++

Irfan Jawed, MD

++

Medical Oncologist/Pain Medicine/Hospice & Palliative Care

++

Lawrence Memorial Hospital Oncology Center

++

Lawrence, Kansas

++

Anal Cancer

++
++

Steven J. Jubelilirer, MD

++

Clinical Professor of Medicine

++

West Virginia University-Charleston

++

Division Director, CAMC Hemophilia Treatment Center

++

Charleston Area Medical Center

++

Charleston, West Virginia

++

Hemophilia

++
++

Judith Karp, MD

++

Professor of Oncology and Medicine

++

John Hopkins University School of Medicine

++

Baltimore, Maryland

++

Leukemia, Acute Lymphoblastic (ADULT); Leukemia, Acute Myeloid

++
++

Lyndon Kim, MD

++

Division of Neuro-Oncology

++

Department of Neurological Surgery

++

Department of Medical Oncology

++

Thomas Jefferson University Hospital

++

Philadelphia, Pennsylvania

++

Brain Cancer

++
++

John M. Kirkwood, MD

++

Usher Professor of Medicine, Dermatology and Translational Science

++

Co-Director, Melanoma and Skin Cancer Program

++

University of Pittsburgh Cancer Institute

++

Pittsburgh, Pennsylvania

++

Melanoma

++
++

Joseph E. Kiss, MD

++

Associate Professor of Medicine

++

Department of Medicine

++

Division of Hematology/Oncology

++

Medical Director, Hemapheresis and Blood Services

++

University of Pittsburgh

++

Pittsburgh, Pennsylvania

++

Transfusion Therapy

++
++

David R. Kohler, PharmD

++

Oncology Clinical Pharmacy Specialist

++

Bethesda, Maryland

++

Drug Preparation and Administration;

++

Antineoplastic Drugs: Preventing and Managing Extravasation

++
++

Kiarash Kojouri, MD, MPH

++

Skagit Valley Hospital Regional Cancer Care Center

++

Seattle Cancer Care Alliance

++

Hematologist-Oncologist

++

Skagit Valley Hospital Regional Cancer Care Clinic

++

Mount Vernon, Washington

++

Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome;

++

Idiopathic Thrombocytopenic Purpura

++
++

Patricia Kropf, MD

++

Assistant Professor of Medicine

++

Fox Chase Cancer Center

++

Temple Health

++

Philadelphia, Pennsylvania

++

Leukemia, Chronic Lymphocytic

++
++

Peter F. Lebowitz, MD, PhD

++

Global Head of Oncology Research and Development

++

Janssen, Pharmaceutical Companies of Johnson & Johnson

++

Spring House, Pennsylvania

++

Adrenocortical Cancer

++
++

John R. Lurain, MD

++

Marcia Stenn Professor of Gynecologic Oncology

++

Gynecologic Oncology Fellowship Program Director

++

Northwestern University, Feinberg School of Medicine

++

Chicago, Illinois

++

Gestational Trophoblastic Neoplasia

++
++

Pier M. Mannucci, MD

++

Professor

++

Scientific Direction

++

IRCCS Ca'Granda Maggiore Policlinico Hospital Foundation

++

Milano, Italy

++

von Willebrand Disease

++
++

Maurie Markman, MD

++

Senior Vice President for Clinical Affairs

++

Cancer Treatment Centers of America

++

Clinical Professor of Medicine

++

Drexel University of College of Medicine

++

Philadelphia, Pennsylvania

++

Endometrial Cancer

++
++

John Marshall, MD

++

Director, The Ruesch Center for the Cure of GI Cancers

++

Chief, Hematology and Oncology

++

Lombardi Comprehensive Cancer Center

++

Georgetown University Medical Center

++

Washington, DC

++

Anal Cancer; Esophageal Cancer

++
++

Pamela W. McDevitt, PharmD, BCOP

++

Oncology Clinical Pharmacy Specialist

++

David Lee Cancer Center

++

Charleston, West Virginia

++

Guidelines for Chemotherapy Dosage Adjustment; Indications for Growth Factors in Hematology-Oncology

++
++

Franco Muggia, MD

++

Professor of Medicine (Oncology)

++

Perlmutter Cancer Center

++

NYU Langone Medical Center

++

New York, New York

++

Vaginal Cancer

++
++

Ashok Nambiar, MD

++

Health Science Associate Clinical Professor

++

Department of Laboratory Medicine

++

Director, Transfusion Medicine

++

Director, Moffitt-Long & Mt. Zion Hospital Tissue Banks

++

UCSF Medical Center

++

University of California, San Francisco

++

San Francisco, California

++

Transfusion Therapy

++
++

Naomi P. O'Grady, MD

++

Medical Director, Procedures, Vascular Access,

++

and Conscious Sedation Services

++

Department of Critical Care Medicine

++

National Institutes of Health

++

Bethesda, Maryland

++

Catheter-Related Bloodstream Infections: Management and Prevention

++
++

Karel Pacak, MD, PhD, DSc

++

Senior Investigator

++

Chief, Section on Medical Neuroendocrinology

++

Eunice Kennedy Shriver NICHD, National Institutes of Health

++

Bethesda, Maryland

++

Pheochromocytoma

++
++

Mauricio Burotto Pichun, MD

++

Medical Oncology

++

Center for Cancer Research

++

National Cancer Institute, National Institutes of Health

++

Bethesda, Maryland

++

Oncologic Emergencies

++
++

Sheila Prindiville, MD, MPH

++

Director, Coordinating Center for Clinical Trials

++

National Cancer Institute

++

Bethesda, Maryland

++

Cancer Screening; Genetics of Common Inherited Cancer Syndromes

++
++

Margaret Ragni, MD, MPH

++

Professor of Medicine and Clinical Translational Science

++

Department of Medicine

++

Division of Hematology-Oncology

++

University of Pittsburgh

++

Director, Hemophilia Center of Western Pennsylvania

++

Pittsburgh, Pennsylvania

++

Hemophilia

++
++

Arun Rajan, MD

++

Staff Clinician

++

Center for Cancer Research

++

National Cancer Institute, National Institutes of Health

++

Bethesda, Maryland

++

Thymic Malignancies

++
++

Ramesh K. Ramanathan, MD, PhD, Sc

++

Virginia G. Piper Cancer Center - Clinical Trials

++

Scottsdale Health Care

++

Scottsdale, Arizona

++

Clinical Professor of Medicine, Translational Genomics Research

++

Institute and College of Medicine

++

University of Arizona

++

Phoenix, Arizona

++

Pancreatic Cancer

++
++

Eddie Reed, MD

++

Clinical Director

++

National Institute on Minority Health and Health Disparities

++

National Institutes of Health

++

Bethesda, Maryland

++

Ovarian Cancer

++
++

Ramesh Rengan, MD, PhD

++

Associate Professor

++

Associate Member, Fred Hutchinson Cancer Research Center

++

Medical Director, SCCA Proton Therapy

++

Department of Radiation Oncology

++

University of Washington

++

Radiation Complications

++
++

Olivier Rixe, MD, PhD

++

Professor of Medicine

++

Director, Experimental Therapeutics Program

++

Leader, Neuro-Oncology Program

++

Georgia Regents University Cancer Center

++

Augusta, Georgia

++

Renal Cell Cancer

++
++

Aldo Roccaro, MD, PhD

++

Dana Farber Cancer Institute

++

Harvard Medical School

++

Boston, Massachusetts

++

Multiple Myeloma

++
++

Griffin P. Rodgers, MD, MACP

++

Chief, Molecular and Clinical Hematology Branch

++

National Heart, Lung and Blood Institute

++

Director, National Institute of Diabetes,

++

Digestive and Kidney Diseases

++

National Institutes of Health

++

Bethesda, Maryland

++

Sickle Cell Disease: Acute Complications

++
++

Peter G. Rose, MD

++

Section Head Gynecologic Oncology

++

Cleveland Clinic Foundation

++

Tenured Professor of Surgery, Oncology and Reproductive Biology

++

Case Western Reserve University

++

Cleveland, Ohio

++

Cervical Cancer

++
++

Rafael Rosell, MD

++

Director, Cancer Biology and Precision Medicine Program

++

Catalan Institute of Oncology,

++

Hospital Germans Trias i Pujol, Badalona

++

Pangaea Biotech, Quirón-Dexeus University Hospital

++

Barcelona, Spain

++

Lung Cancer

++
++

Julia Schaefer-Cutillo, MD

++

Medical Oncologist

++

Hudson Valley Hematology Oncology

++

Poughkeepsie, New York

++

Lymphoma, Non-Hodgkin

++
++

Werner Scheithauer, MD

++

Professor

++

Department of Internal Medicine I

++

Division of Oncology

++

Vienna University Medical School, Vienna University Hospital

++

Vienna, Austria

++

Biliary: Gallbladder Cancer and Cholangiocarcinoma

++
++

Lee S. Schwartzberg, MD, FACP

++

Chief, Division of Hematology Oncology

++

Professor of Medicine

++

The University of Tennessee Health Science Center

++

Memphis, Tennessee

++

Indications for Growth Factors in Hematology-Oncology

++
++

Avni Shah, MD

++

Medical Oncologist

++

Genitourinary Malignancies Branch

++

Center for Cancer Research

++

National Cancer Institute, National Institutes of Health

++

Bethesda, Maryland

++

Prostate Cancer

++
++

Manish A. Shah, MD

++

Associate Professor of Medicine

++

Director, Gastrointestinal Oncology

++

Weill Cornell Medical College of Cornell University

++

New York-Presbyterian

++

New York, New York

++

Gastric Cancer

++
++

Reem Abozena Shalabi, PharmD, BCOP

++

Clinical Pharmacy Specialist

++

Blood and Marrow Transplantation

++

National Institutes of Health

++

Bethesda, Maryland

++

Indications for Bone-Modifying Agents in Hematology-Oncology

++
++

Britt Skogseid, MD, PhD

++

Professor of Endocrine Tumorbiology

++

Department of Endocrine Oncology

++

Uppsala University Hospital

++

Uppsala, Sweden

++

Pancreatic Endocrine Tumors

++
++

Roy E. Smith, MD, MS

++

Professor of Medicine

++

Division of Hematology/Oncology

++

University of Pittsburgh Cancer Institute

++

Pittsburgh, Pennsylvania

++

Venous Catheter-Related Thrombosis

++
++

Pol Specenier, MD, PhD

++

Antwerp University Hospital

++

Edegem, Belgium

++

Head and Neck Cancers

++
++

David R. Spigel, MD

++

Director, Lung Cancer Research Program

++

Sarah Cannon Research Institute

++

Nashville, Tennessee

++

Carcinoma of Unknown Primary

++
++

Diana C. Stripp, MD

++

Assistant Professor

++

Department of Radiation Oncology

++

University of Pennsylvania

++

Hospital of University of Pennsylvania

++

Philadelphia, Pennsylvania

++

Radiation Complications

++
++

Martin S. Tallman, MD

++

Chief of the Leukemia Service

++

Department of Medicine

++

Memorial Sloan Kettering Cancer Center

++

Professor of Medicine

++

Weill Cornell Medical College

++

New York, New York

++

Leukemia, Hairy Cell

++
++

Ahmad A. Tarhini, MD, PhD

++

Associate Professor of Medicine, Clinical and Translational Science

++

Department of Medicine

++

Division of Hematology/Oncology

++

University of Pittsburgh

++

Pittsburgh, Pennsylvania

++

Melanoma

++
++

Ayalew Tefferi, MD

++

Professor of Medicine

++

Division of Hematology

++

Mayo Clinic

++

Rochester, Minnesota

++

Myeloproliferative Neoplasms

++
++

Arafat Tfayli, MD

++

Associate Professor of Clinical Medicine

++

NK Basile Cancer Institute

++

American University of Beirut Medical Center

++

Beirut, Lebanon

++

Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndrome; Idiopathic Thrombocytopenic Purpura

++
++

Anish Thomas, MD

++

Thoracic and Gastrointestinal Oncology Branch

++

National Cancer Institute, National Institutes of Health

++

Bethesda, Maryland

++

Mesothelioma

++
++

Susanna Ulahannan, MD

++

Center for Cancer Research

++

National Cancer Institute, National Institutes of Health

++

Bethesda, Maryland

++

Biliary: Gallbladder Cancer and Cholangiocarcinoma

++
++

Verna Vanderpuye, MD

++

Radiotherapy Consultant

++

National Centre of Radiotherapy and Nuclear Medicine

++

Korle Bu Teaching Hospital

++

Accra, Ghana

++

Mesothelioma

++
++

JB Vermorken, MD, PhD

++

Emeritus Professor of Oncology

++

Department of Medical Oncology

++

Antwerp University Hospital

++

Antwerp, Belgium

++

Head and Neck Cancers

++
++

Daniel D. Von Hoff, MD, FACP

++

Physician in Chief, Distinguished Professor

++

Translational Genomics Research Institute

++

Professor of Medicine, Mayo Clinic

++

Chief Scientific Officer, Scottsdale Healthcare

++

Medical Director of Research and Scientific Medical Officer,

++

US Oncology Research

++

Senior Investigator

++

Clinical Professor of Medicine

++

Translational Genomics Research Institute

++

University of Arizona Cancer Center

++

Phoenix, Arizona

++

Pancreatic Cancer

++
++

Nicholas J. Vogelzang, MD

++

Medical Oncologist

++

U.S. Oncology

++

Comprehensive Cancer Centers of Nevada

++

Las Vegas, Nevada

++

Mesothelioma

++
++

Charles F. von Gunten, MD, PhD

++

Vice President, Medical Affairs

++

Hospice and Palliative Medicine for OhioHealth

++

Columbus, Ohio

++

Hospice Care and End-of-Life Issues

++
++

David E. Weissman, MD

++

Director of the Palliative Care Center

++

Professor of Medicine

++

Division of Hematology and Oncology

++

Medical College of Wisconsin

++

Milwaukee, Wisconsin

++

Hospice Care and End-of-Life Issues

++
++

Sam Wells, MD

++

Center for Cancer Research

++

National Cancer Institute, National Institutes of Health

++

Bethesda, Maryland

++

Thyroid Cancer

++
++

Brigitte Widemann, MD

++

Senior Investigator

++

Pediatric Oncology Branch

++

Center for Cancer research

++

National Cancer Institute, National Institutes of Health

++

Bethesda, Maryland

++

Sarcomas

++
++

Neal S. Young, MD

++

Chief, Hematology Branch

++

National Heart, Lung, and Blood Institute,

++

National Institutes of Health

++

Bethesda, Maryland

++

Aplastic Anemia; Myelodysplastic Syndromes

++
++

Wenhui Zhu, MD, PhD

++

Seidman Cancer Center

++

Southwest General Hospital

++

Middleburg Heights, Ohio

++

Prostate Cancer

++
++

Jeffrey I. Zwicker, MD

++

Assistant Professor of Medicine

++

Division of Hematology-Oncology

++

Beth Israel Deaconess Medical Center, Harvard Medical School

++

Boston, Massachusetts

++

The Hypercoagulable State

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.